Glenmark Pharma shares falls 2% after subsidiary stake sale to Nirma

According to a regulatory filing, Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma to divest 75 percent stake in Glenmark Life Sciences for Rs 5,651.5 crore, at a price of Rs 615 per share.

Related Keywords

Sekhmet Pharmaventures ,Glenmark Pharma ,Glen Saldanha ,Motilal Oswal ,Glenmark Lifesciences ,Glenmark Life Sciences For Rs ,Glenmark Life Sciences ,Glenmark Life Sciences To Nirma ,Glenmark Pharmaceuticals ,Glenmark Life ,Irma ,